Skip to main content

Table 1 Participant characteristics

From: Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugs

Characteristics

Overall

Participants identified from study sites

Participants referred from other sources

p

Study site locations, n (%)

    

 Rahmat

79/199 (39.7)

36/95 (37.9)

43/104 (41.3)

< 0.001a

 Kuala Dungun

22/199 (11.1)

22/95 (23.2)

0/104 (0)

 

 Bukit Tunggal

47/199 (23.6)

19/95 (20.0)

28/104 (26.9)

 

 Kuala Berang

51/199 (25.6)

18/95 (18.9)

33/104 (31.7)

 

Age, years, mean (SD)

44.0 (6.5)

43.9 (6.5)

44.0 (6.6)

0.894b

Gender, n (%)

    

 Male

199/199 (100)

95/95 (100)

104/104 (100)

–

Ethnicity, n (%)

    

 Malay

199/199 (100)

95/95 (100)

104/104 (100)

–

Living with HIV, n (%)

38/199 (19.1)

26/95 (27.4)

12/104 (11.5)

0.005a

Living with HBV, n (%)

2/199 (1.0)

0/95 (0)

2/104 (1.9)

0.499c

Timepoint of anti-HCV test, n (%)

    

 Within 1 year

119/199 (59.8)

55/95 (57.9)

64/104 (61.5)

0.601a

 ≥ 1 year

80/199 (40.2)

40/95 (42.1)

40/104 (38.5)

 
  1. HBV hepatitis B virus, HIV human immunodeficiency virus, n size of sample, SD standard deviation
  2. aPearson’s Chi-square test
  3. bIndependent t-test
  4. bFisher’s exact test